Oric Pharmaceuticals, Inc. Common Stock ORIC
$11.31
-4.23%
at last close
Market Cap$1.22 billion
P/E Ratio—
Div Yield—
Volume1.16M
52-Week Range
$7.23$14.93
Analyst Ratings
- Consensus
- Buy — 11 Buy · 1 Hold · 0 Sell (12 analysts)
- Avg. Price Target
- $21.27 (+88.1% upside)
Key Stats
- Today's Range
- $11.29 – $11.91
- 50-Day Range
- $10.64 – $14.68
- 52-Week Range
- $7.23 – $14.93
- Volume
- 1.16 million shs
- Average Volume
- 1.47 million shs
- Market Cap
- $1.22 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.65%
- Days to Cover
- 1.37
About Oric Pharmaceuticals, Inc. Common Stock
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Related Stocks
Compare head-to-head: ORIC vs LLY·ORIC vs JNJ·ORIC vs ABBV·ORIC vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.